Available Forms: Tablets, Capsules
Available Strengths: 4 mg, 8 mg, 12 mg, 16 mg, 24 mg
Reference Brands: Razadyne (USA), Reminyl (EU)
Category: Neurology
Galantamine is used to treat mild to moderate Alzheimerβs disease and other forms of dementia by improving cognitive function. It works as a reversible acetylcholinesterase inhibitor and also modulates nicotinic receptors to enhance cholinergic neurotransmission in the brain. This dual mechanism helps improve memory, awareness, and the ability to perform daily activities.
Quick Response Guaranteed | Verified Suppliers
Galantamine Hydrobromide is used to treat mild to moderate dementia associated with Alzheimer’s disease. It helps improve memory, awareness, and the ability to perform daily functions by increasing the levels of acetylcholine, a neurotransmitter involved in learning and memory.
Galantamine Hydrobromide is made from the active ingredient galantamine hydrobromide, a tertiary alkaloid derived from the bulbs of certain flowers such as snowdrops and daffodils. It acts as a reversible acetylcholinesterase inhibitor, enhancing cholinergic function in the brain.
Galantamine Hydrobromide is marketed under trade names such as Razadyne, Reminyl, and Nivalin.
Galantamine Hydrobromide is manufactured by several pharmaceutical companies including Janssen Pharmaceuticals, Sun Pharma, and Teva Pharmaceuticals.
The generic name of Galantamine Hydrobromide is Galantamine Hydrobromide.
Brand names of Galantamine Hydrobromide include Razadyne, Reminyl, and Nivalin.
Galantamine Hydrobromide is manufactured in countries such as the United States, India, and the United Kingdom by companies like Janssen Pharmaceuticals, Sun Pharma, and Teva Pharmaceuticals.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP